GUARDANT HEALTH INC
GUARDANT HEALTH INC
Share · US40131M1099 · GH · A2N5RY (XNAS)
Overview Financial Indicators
45,49 USD
0,33 % 0,15 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
24.07.2025 20:34

Current Prices from GUARDANT HEALTH INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
GH
USD
24.07.2025 20:34
45,49 USD
0,04 USD
+0,09 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -1,54 % -9,00 % -4,71 % -3,64 % 43,14 % -44,25 %

Company Profile for GUARDANT HEALTH INC Share

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.

Invested Funds

The following funds have invested in: GUARDANT HEALTH INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
439,54
Percentage (%)
1,03 %

Company Data

Name GUARDANT HEALTH INC
Company Guardant Health, Inc.
Symbol GH
Website https://guardanthealth.com
Primary Exchange XNAS NASDAQ
WKN A2N5RY
ISIN US40131M1099
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Dr. Helmy Eltoukhy Ph.D.
Market Capitalization 6 Mrd.
Country United States of America
Currency USD
Employees 2,0 T
Address 505 Penobscot Drive, 94063 Palo Alto
IPO Date 2018-10-04

Ticker Symbols

Name Symbol
Frankfurt 5GH.F
NASDAQ GH

More Shares

Investors who GUARDANT HEALTH INC hold also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
BEAM THERAPEUTICSCS INC
BEAM THERAPEUTICSCS INC Share
CODEXIS INC
CODEXIS INC Share
DELTEX MEDICAL GRP
DELTEX MEDICAL GRP Share
EDWARDS LIFESCIENCES CORP
EDWARDS LIFESCIENCES CORP Share
ILLUMINA INC
ILLUMINA INC Share
INTELLIA THERAPEUTICSCS INC
INTELLIA THERAPEUTICSCS INC Share
MEDTRONIC PLC
MEDTRONIC PLC Share
MOBEUS INCOME & GROWTH 4 VCT PLC - ORD 1P
MOBEUS INCOME & GROWTH 4 VCT PLC - ORD 1P Share
STEICO SE
STEICO SE Share
THERMO FISHER SCIENTIFIC INC
THERMO FISHER SCIENTIFIC INC Share
VERTEX PHARMACEUTICALS INC
VERTEX PHARMACEUTICALS INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025